# Diabetes Research Hub — Iteration Run Report

**Date:** 2026-06-23 (Tuesday)
**Agent:** Automated research iteration (scheduled)
**State version loaded:** 285 papers (all VETTED), 56 validated paths, 15 gaps, 23 queue items

---

## Summary

Routine maintenance run. No vetting backlog and most gap audits not due until July, so the run focused on the mandated every-run credibility sweep, re-validation of the two oldest stale PARTIALLY_VALIDATED paths, and a targeted pipeline-integrity check. Two external evidence searches were run; both reaffirmed existing ratings and one yielded a PMID correction.

## Work completed

### 1. Credibility sweep (Step 4 — every run) — CLEAN
- No fabricated PMIDs (>42,000,000) in any `.py` script.
- No "zero SAEs" / "zero rejection" claims.
- Three `achieves` matches reviewed and all legitimate: TTP399 tissue-selectivity *mechanism* description; LADA diagnostic-model cost-effectiveness metric; microbiome-ML macro-AUC metric. None are overstated curative preclinical claims.

### 2. Path re-validation x2 (Step 1 — `validate_path`)
**`vitamin_d -> autoimmune`** (last validated 2026-06-10) — **REAFFIRMED PARTIALLY_VALIDATED**
- 2025 systematic review/meta-analysis (Front Immunol, PMC12014702; National University of Singapore, 15 studies) finds **no significant effect** of vitamin D supplementation on incident T1D (pooled OR 0.55, 95% CI 0.22–1.38) or islet autoimmunity (pooled OR 0.91, 95% CI 0.67–1.25); T1D RR 0.66 (0.41–1.06), near but not significant.
- Observational/cohort protective signal (Finnish birth cohort 2000 IU/day; small new-onset RCTs showing ↑Tregs, ↓GAD65) persists but is **not confirmed at RCT/MA level**. No promotion. External PMIDs: 40988828, 17130571.

**`tacrolimus -> inflammation`** (last validated 2026-06-12) — **REAFFIRMED PARTIALLY_VALIDATED**
- Bidirectional/context-dependent effect confirmed: anti-inflammatory in T cells (NF-κB inhibition, PLOS One PMID 23573283); pro-inflammatory in vasculature (CNI-induced endothelial activation via TLR4 → ROS/NF-κB, Sci Rep srep27915 **PMID 27295076**).
- **PMID correction:** vascular-inflammation paper is **27295076** (earlier note had 27291296). External PMIDs: 23573283, 27295076.

### 3. Pipeline integrity (Steps 3 & 5)
- Only `build_nutrition_beta.py` changed since the last full rebuild (2026-06-13 → mod 2026-06-19, Gap #13 reconciliation). Re-ran it: clean (exit 0, 41,858 bytes).
- All 7 key JSON outputs parse cleanly: `agent_state.json`, `research_paths.json`, `validated_research_paths.json`, `gap_evidence.json`, `evidence_network.json`, `combination_validation.json`, `extracted_corpus_data.json`.
- Full network-heavy `run_quality_improvements.py` (41/41 [OK] on 2026-06-13) not re-run — no script changes warrant it.

### 4. Weekly PubMed sweep
- Tuesday — not run (sweep is Monday-only). Last sweep 2026-06-22 found no new breakthrough papers.

## State changes saved
- `validated_paths`: updated `vitamin_d -> autoimmune` and `tacrolimus -> inflammation` (date 2026-06-23, refreshed evidence + PMID correction).
- `run_history`: appended 2026-06-23 entry (now 70 runs).
- `work_queue` item (validate_path): next batch set to `metformin -> cardiovascular` (oldest remaining PARTIALLY, last 2026-06-14).
- Backup written: `agent_state.json.bak_2026-06-23`.

## Outstanding blocker (queue priority 1)
Git commit/push remains blocked in the sandbox — OneDrive denies removal of `.git/index.lock` / `HEAD.lock`, and there is no GitHub auth for push. Repo is ~40+ commits ahead of origin/main. **User action required** from local PowerShell at `C:\Users\justi\OneDrive\Diabetes_Research`:

```
del .git\index.lock
git add -A
git commit -m "Daily iteration 2026-06-23: path re-validation + credibility sweep"
git push
```

All 2026-06-23 changes are saved to disk and will persist for the next run regardless.
